Estimating HIV incidence is critical for identifying groups at risk for HIV infection, planning and targeting interventions, and evaluating these interventions over time. The use of reliable estimation methods for HIV incidence is thus of high importance. The aim of this study was to compare methods for estimating HIV incidence in a population-based cross-sectional survey.
Design/Methods:
The incidence estimation methods evaluated included assay-derived methods, a testing history-derived method, and a probability-based method applied to data from the Ndhiwa HIV Impact in Population Survey (NHIPS). Incidence rates by sex and age and cumulative incidence as a function of age were presented.
Results:
HIV incidence ranged from 1.38 [95% confidence interval (CI) 0.67–2.09] to 3.30 [95% CI 2.78–3.82] per 100 person-years overall; 0.59 [95% CI 0.00–1.34] to 2.89 [95% CI 0.86–6.45] in men; and 1.62 [95% CI 0.16–6.04] to 4.03 [95% CI 3.30–4.77] per 100 person-years in women. Women had higher incidence rates than men for all methods. Incidence rates were highest among women aged 15–24 and 25–34 years and highest among men aged 25–34 years.
Conclusion:
Comparison of different methods showed variations in incidence estimates, but they were in agreement to identify most-at-risk groups. The use and comparison of several distinct approaches for estimating incidence are important to provide the best-supported estimate of HIV incidence in the population.
Get full access to this article
View all access options for this article.
References
1.
GrasslyNC, GarnettGP, SchwartlanderB, GregsonS, AndersonRM: The effectiveness of HIV prevention and the epidemiological context. Bull World Health Organ, 2001; 79:1121–1132.
2.
BrookmeyerR: Measuring the HIV/AIDS epidemic: Approaches and challenges. Epidemiol Rev, 2010; 32:26–37.
3.
BuschMP, PilcherCD, MastroTD, KaldorJ, VercauterenG, RodriguezW, et al.: Beyond detuning: 10 years of progress and new challenges in the development and application of assays for HIV incidence estimation. AIDS, 2010; 24:2763–2771.
4.
Le VuS, PillonelJ, SemailleC, BernillonP, Le StratY, MeyerL, et al.: Principles and uses of HIV incidence estimation from recent infection testing—A review. Euro Surveill, 2008; 13.
5.
McWalterTA, WelteA: A comparison of biomarker based incidence estimators. PLoS One, 2009; 4:e7368.
6.
McWalterTA, WelteA: Relating recent infection prevalence to incidence with a sub-population of assay non-progressors. J Math Biol, 2010; 60:687–710.
7.
BarnighausenT, McWalterTA, RosnerZ, NewellML, WelteA: HIV incidence estimation using the BED capture enzyme immunoassay: Systematic review and sensitivity analysis. Epidemiology, 2010; 21:685–697.
8.
KassanjeeR, McWalterTA, BarnighausenT, WelteA: A new general biomarker-based incidence estimator. Epidemiology, 2012; 23:721–728.
9.
ShisanaO, RehleT, SimbayiLC, ZumaK, JoosteS, ZunguN, et al.: South African National HIV Prevalence, Incidence and Behaviour Survey, 2012. HSRC Press, Cape Town, 2014.
10.
National AIDS and STI Control Programme (NASCOP) Kenya. Kenya AIDS Indicator Survey 2012: Final Report. NASCOP, Nairobi, 2014.
11.
AalenOO, FarewellVT, De AngelisD, DayNE, GillON: A Markov model for HIV disease progression including the effect of HIV diagnosis and treatment: Application to AIDS prediction in England and Wales. Stat Med, 1997; 16:2191–2210.
12.
SommenC, AlioumA, CommengesD: A multistate approach for estimating the incidence of human immunodeficiency virus by using HIV and AIDS French surveillance data. Stat Med, 2009; 28:1554–1568.
13.
NdawinzJD, CostagliolaD, SupervieV: New method for estimating HIV incidence and time from infection to diagnosis using HIV surveillance data: Results for France. AIDS, 2011; 25:1905–1913.
14.
WilliamsB, GouwsE, WilkinsonD, KarimSA: Estimating HIV incidence rates from age prevalence data in epidemic situations. Stat Med, 2001; 20:2003–2016.
15.
HallettTB, ZabaB, ToddJ, LopmanB, MwitaW, BiraroS, et al.: Estimating incidence from prevalence in generalised HIV epidemics: Methods and validation. PLoS Med, 2008; 5:e80.
16.
HallettTB, StoverJ, MishraV, GhysPD, GregsonS, BoermaT: Estimates of HIV incidence from household-based prevalence surveys. AIDS, 2010; 24:147–152.
17.
MisiriHE, EdrissA, AalenOO, DahlFA: Estimation of HIV incidence in Malawi from cross-sectional population-based sero-prevalence data. J Int AIDS Soc, 2012; 15:14.
18.
MahianeGS, OuifkiR, BrandH, DelvaW, WelteA: A general HIV incidence inference scheme based on likelihood of individual level data and a population renewal equation. PLoS One, 2012; 7:e44377.
19.
World Health Organization: When and How to Use Assays for Recent Infection to Estimate HIV Incidence at a Population Level. World Health Organization, Geneva, 2011.
20.
MamanD, ZehC, MukuiI, KirubiB, MassonS, OpoloV, et al.: Cascade of HIV care and population viral suppression in a high-burden region of Kenya. AIDS, 2015; 29:1557–1565.
21.
MamanD, MassonS, MukuiI, KirubiB, RicheB, ZehC, et al.: High incidence despite increasing coverage in Western Kenya: The Ndhiwa HIV Impact in Population Study. In: 17th International Conference on AIDS and STIs in Africa (ICASA). Cape Town, South Africa, 2013.
22.
MamanD, MukuiI, KirubiB, RicheB, ZehC, MassonS, et al.: Good program coverage in high HIV prevalence settings in Western Kenya: Preliminary results of the Ndhiwa HIV Impact in Population Study. In: International AIDS Conference 2013. Kuala Lumpur, 2013.
23.
National AIDS and STI Control Programme (NASCOP) Kenya. Guidelines for HIV Testing and Counseling in Kenya. 2nd edition. NASCOP, Nairobi, 2010.
24.
QuinnTC, BrookmeyerR, KlineR, ShepherdM, ParanjapeR, MehendaleS, et al.: Feasibility of pooling sera for HIV-1 viral RNA to diagnose acute primary HIV-1 infection and estimate HIV incidence. AIDS, 2000; 14:2751–2757.
25.
MasciotraS, McDougalJS, FeldmanJ, SprinkleP, WesolowskiL, OwenSM: Evaluation of an alternative HIV diagnostic algorithm using specimens from seroconversion panels and persons with established HIV infections. J Clin Virol, 2011; 52Suppl 1:S17–S22.
26.
EshlemanSH, HughesJP, LaeyendeckerO, WangJ, BrookmeyerR, Johnson-LewisL, et al.: Use of a multifaceted approach to analyze HIV incidence in a cohort study of women in the United States: HIV Prevention Trials Network 064 Study. J Infect Dis, 2013; 207:223–231.
27.
KassanjeeR, PilcherCD, BuschMP, MurphyG, FacenteSN, KeatingSM, et al.: Viral load criteria and threshold optimization to improve HIV incidence assay characteristics. AIDS, 2016; 30:2361–2371.
28.
ZehC, MamanD, OmondiH, MorwabeA, OdhiamboC, KirubiB, et al.: False recent rates for two recent infection testing algorithms, South Nyanza, Kenya. In: Conference on Retrovirus and Opportunistic Infections. Seattle, WA, 2015.
29.
KassanjeeR, PilcherCD, KeatingSM, FacenteSN, McKinneyE, PriceMA, et al.: Independent assessment of candidate HIV incidence assays on specimens in the CEPHIA repository. AIDS, 2014; 28:2439–2449.
30.
ZehC, InzauleSC, OndoaP, NafisaLG, KasembeliA, OtienoF, et al.: Molecular epidemiology and transmission dynamics of recent and long-term HIV-1 infections in Rural Western Kenya. PLoS One, 2016; 11:e0147436.
31.
BlaizotS, RicheB, MamanD, MukuiI, KirubiB, EtardJF, et al.: Estimation and short-term prediction of the course of the HIV epidemic using demographic and health survey methodology-like data. PLoS One, 2015; 10:e0130387.
32.
National AIDS and STI Control Programme (NASCOP) Kenya, National AIDS Control Council. Kenya HIV Estimates. NASCOP, Nairobi, 2014.
33.
National AIDS and STI Control Programme (NASCOP) Kenya, National AIDS Control Council. Kenya HIV Prevention Revolution Road Map: Count down to 2030. HIV Prevention Everyone's Business. NASCOP, Nairobi, 2014.
34.
AndersonSJ, CherutichP, KilonzoN, CreminI, FechtD, KimangaD, et al.: Maximising the effect of combination HIV prevention through prioritisation of the people and places in greatest need: A modelling study. Lancet, 2014; 384:249–256.
35.
Joint United Nations Programme on HIV/AIDS (UNAIDS). Global Report: UNAIDS Report on the Global AIDS Epidemic. Joint United Nations Programme on HIV/AIDS (UNAIDS), Geneva, 2013.
36.
HargreavesJR, BonellCP, MorisonLA, KimJC, PhetlaG, PorterJD, et al.: Explaining continued high HIV prevalence in South Africa: Socioeconomic factors, HIV incidence and sexual behaviour change among a rural cohort, 2001–2004. AIDS, 2007; 21Suppl 7:S39–S48.
37.
BarnighausenT, HosegoodV, TimaeusIM, NewellML: The socioeconomic determinants of HIV incidence: Evidence from a longitudinal, population-based study in rural South Africa. AIDS, 2007; 21Suppl 7:S29–S38.
38.
RehleT, JohnsonL, HallettT, MahyM, KimA, OdidoH, et al.: A comparison of South African National HIV incidence estimates: A critical appraisal of different methods. PLoS One, 2015; 10:e0133255.
39.
KimAA, NgangaL, MukuiI, WamicweJ, MwanyumbaS, BowenN, et al.: Estimating national coverage of antiretroviral therapy among HIV-infected persons using multiple methods, Kenya 2012. In: Conference on HIV Pathogenesis, Treatment, & Prevention 2015. Vancouver, Canada. Abstract no. TUAD0103.
40.
AbuelezamNN, GaolatheT, ChakalisaU, KadimaE, KhanN, MoyoS, et al.: Estimation of HIV incidence using retrospectively-collected HIV testing history in Botswana. In: 21st International AIDS Conference (AIDS 2016). Durban, South Africa, 2016.
41.
MossongJ, GrapsaE, TanserF, BarnighausenT, NewellML: Modelling HIV incidence and survival from age-specific seroprevalence after antiretroviral treatment scale-up in rural South Africa. AIDS, 2013; 27:2471–2479.
42.
LongoszAF, MorrisonCS, ChenPL, BrandHH, ArtsE, NankyaI, et al.: Comparison of antibody responses to HIV infection in Ugandan women infected with HIV subtypes A and D. AIDS Res Hum Retroviruses, 2015; 31:421–427.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
